Arexvy

Arexvy (respiratory syncytial virus vaccine, adjuvanted) is a vaccine used for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in individuals aged 60 years and older.

Recommended Dosage: The recommended dose of Arexvy is 0.5 mL administered by intramuscular (IM) injection only, preferably in the upper arm or deltoid muscle. The requirement for revaccination with a subsequent dose of Arexvy (IM) intramuscular injection has not been developed. Do not administer it to anyone with a known history of a severe allergic reaction (e.g., anaphylaxis) to any component of Arexvy.

• Certain relevant medical treatments as well as supervision must exist in order to manage all the possible anaphylactic reactions after the administration of the Arexvy vaccine.
  
• Syncope (fainting) may develop in association with the use of injectable vaccines, including respiratory syncytial virus vaccine, adjuvanted. Procedures must be in place to avoid injury from fainting. 
  
• Immunocompromised individuals, including those receiving immunosuppressive treatment, may have a diminished immune response to therapy with Arexvy. 
  
• Postpone the vaccination in those suffering from an acute severe febrile illness. The existence of a minimal infection, such as a cold, should not cause deferral of vaccination.
  
• Avoid administering this vaccine intravascularly/intradermally. As with other intramuscular (IM) injections, Arexvy needs to be given with a lot of caution to those with thrombocytopenia or any coagulation condition since bleeding may occur after intramuscular (IM) administration to these individuals.
  
• If Arexvy 0.5 mL is to be administered concomitantly with other injectable vaccines, the vaccines must always be administered at different injection sites. Concomitant use of Arexvy with other vaccines has not been evaluated.
  
• The use of Arexvy needs to be avoided during pregnancy. There are no findings on the excretion of Arexvy in human milk. This medicinal product is not recommended for breastfeeding/lactating women.
  

What documents are required to import AREXVY to India?

AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) suspension for intramuscular injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients ID proof (issued by the government of India)

The order will be confirmed only after the receipt of:

• A valid prescription from Doctor
  
• Import permit if applicable

AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) is a (prescription drug, prescription medicine, or prescription medication) pharmaceutical drug that legally requires a valid medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Arexvy in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

IPN (Indian Pharma Network) can facilitate the supply of AREXVY (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Arexvy price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the AREXVY (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Arexvy®?

Respiratory Syncytial Virus Vaccine, Adjuvanted is a Generic Name for the trade name drug Arexvy®.

What is the Manufacturer’s Name of Arexvy®?

Arexvy® is manufactured by GlaxoSmithKline Biologicals.

Is Arexvy® approved by the FDA?

Yes, Arexvy® is approved by the FDA. Date of first approval: May 3, 2023.

Where can I get Arexvy® at the best price in India?

To get the best Arexvy 0.5 mL price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Arexvy®, a valid medical prescription is needed from a treating physician.

What is the dosage and form of Arexvy® supplied?

Arexvy® is supplied as two components: A single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes/needles) for intramuscular use. 

Who can get Arexvy®?

Arexvy® is available for individuals aged 60 years and older.

What are the most common side effects of Arexvy®? 

The most common side effects of Arexvy® are headache, injection site pain, myalgia, arthralgia, and fatigue.

How much does Arexvy® cost in India?

The cost of Arexvy in India can vary. In order to procure this medication legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Arexvy®?

Storage prior to Reconstitution: Store refrigerated between 2°C and 8°C (36°F and 46°F) in the original package to protect vials from light. Avoid freezing it. Discard in case it has been frozen.

Storage after Reconstitution: Administer promptly or store in the refrigerator between 2°C and 8°C (36°F to 46°F) or at room temperature [up to 25°C (77°F)] for up to four hours before use. Protect from light.

Is it safe to buy Arexvy® online in India?

Yes, one can buy Arexvy online in India at the lowest price from the Indian Pharma Network (IPN) if the medicine Arexvy® is not (yet) registered or available in their country. We can help facilitate the supply of Arexvy® through legal channels.